Harlan Levine, M.D., is president of strategy and business ventures for City of Hope. In this role, he is accountable for strategy, innovation and growth, drug commercialization, payer strategies and the Center for International Medicine. He also serves as the chairman of the board of AccessHopeTM, City of Hope’s subsidiary focused on serving the employer market and making leading-edge cancer care available to all regardless of geography.
Before City of Hope, Dr. Levine held executive roles at UnitedHealth Group, Towers Watson and Anthem Inc. He currently serves as a board member for Active Life Scientific, a board member and secretary for BioScienceLA, and a member of the Keck Graduate Institute’s Board of Trustees. In addition, he is a long-term strategic advisor to the Founder/CEO, now chairman of the board of Quantum Health, a member of the Accessibility and Affordability Working Group for California Institute for Regenerative Medicine, and a workgroup fellow for Health Evolution Forum’s New Models of Care Delivery.
He is certified by the American Board of Internal Medicine and licensed by the Medical Board of California. He earned his undergraduate degree from Harvard College and his medical degree from the University of California, San Francisco. He interned at Mount Zion Hospital and Medical Center in San Francisco and completed his residency in internal medicine at Cedars-Sinai Health System in Los Angeles.
Education & Experience
M.D., University of California, San Francisco, School of Medicine, San Francisco, CA
B.A., Harvard University, Cambridge, MA
Internal Medicine, Cedars-Sinai Health System, Los Angeles, CA
Mount Zion Hospital and Medical Center, San Francisco, CA